Abstract
A cancer biomarker is a substance that indicates the presence of cancer. It could be secreted by a tumor or result from a specific response to the cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. This chapter outlines the sources of the most up-to-date information on the regulatory bodies, journals on biomarkers, journals on cancer, professional bodies, books, emerging techniques and platforms, and websites that are relevant to an evidence-based use of biomarkers in health and disease.
References
Atkinson AJ, Colburn WA, DeGruttola VG, DeMets DL, Downing GJ, Hoth DF, Oates JA, Peck CC, Schooley RT, Spilker BA, Woodcock J, Zeger SL. NCI-FDA Biomarkers Definitions Working Group; Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69:89–95.
Acknowledgement
We would like to thank the following authors for contributing to the development of this resource (Carnero A, Clarke S, De Rossi A, Diakos C, Noh D-Y, Schraml PH, Takenaka S, Wonshik H, Yi L).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Rajendram, R., Rajendram, R., Patel, V.B., Preedy, V.R. (2015). Biomarkers in Health and Disease: Cancer Further Knowledge. In: Preedy, V., Patel, V. (eds) Biomarkers in Cancer. Biomarkers in Disease: Methods, Discoveries and Applications. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7681-4_47
Download citation
DOI: https://doi.org/10.1007/978-94-007-7681-4_47
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-7680-7
Online ISBN: 978-94-007-7681-4
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences